Page last updated: 2024-08-25

ketorolac tromethamine and Animal Mammary Carcinoma

ketorolac tromethamine has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dominguez, D; Grimes, MM; Hathaway, HJ; Hudson, LG; Kusewitt, DF; Peretti, AS; Prossnitz, ER; Rivera, MR; Wandinger-Ness, A	1

Other Studies

1 other study(ies) available for ketorolac tromethamine and Animal Mammary Carcinoma

Article	Year
The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice. The American journal of pathology, 2018, Volume: 188, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Differentiation; Cell Proliferation; Disease Progression; Drug Administration Schedule; Drug Evaluation, Preclinical; Epithelial Cells; Female; Ketorolac Tromethamine; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Mice, Transgenic; Polyomavirus	2018

Article

Year

The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice.

The American journal of pathology, 2018, Volume: 188, Issue:2

Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Differentiation; Cell Proliferation; Disease Progression; Drug Administration Schedule; Drug Evaluation, Preclinical; Epithelial Cells; Female; Ketorolac Tromethamine; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Mice, Transgenic; Polyomavirus

2018